Understanding Hesitant Adopters
了解犹豫不决的采用者
基本信息
- 批准号:10399324
- 负责人:
- 金额:$ 25.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAfrican AmericanArkansasAwardBehaviorCOVID-19COVID-19 disparityCOVID-19 morbidityCOVID-19 mortalityCOVID-19 vaccinationCOVID-19 vaccineCause of DeathCellsCharacteristicsColorCommunitiesConsent FormsDataData CollectionDeath RateDevelopmentDigit structureEthnic OriginEthnic groupFeedbackFeelingHealth PersonnelHispanicsHospitalizationImmunityImmunization ProgramsIndividualInstitutional Review BoardsInterventionInterviewKnowledgeLatinoLiteratureMethodsMinority GroupsModelingMotivationNot Hispanic or LatinoParticipantPatternPopulationProcessProtocols documentationQualitative MethodsRaceRecommendationReportingResearchResearch DesignResearch PersonnelRoleSamplingSocial ProcessesSourceSurveysTelephoneThinkingTimeTrustUnited StatesVaccinatedVaccinationVaccinesVariantbasecommunity based participatory researchdesigndisparity reductionethnic minority populationexperiencehealth disparityhigh riskhospitalization ratesinfection rateinnovationmembermortalitypandemic diseasepublic health relevanceracial and ethnicracial and ethnic disparitiesracial disparityracial minorityuptakevaccine acceptancevaccine hesitancywillingness
项目摘要
ABSTRACT
COVID-19 has become one of the leading causes of death in the United States (US), and racial and ethnic
minority groups experience higher risks of exposure, hospitalization, and death due to COVID-19. Population
immunity through the uptake of a vaccine is critical to stopping the spread of COVID-19; however, racial and
ethnic disparities in vaccine hesitancy raise concerns about whether vaccination programs will further widen
COVID-19 disparities. Minority populations have reported greater hesitancy to get the COVID-19 vaccine, with
some communities of color half as likely to get the COVID-19 vaccine compared to Whites. To reduce
disparities in COVID-19-related morbidity and mortality, we must understand and address racial disparities in
vaccine behavior. The proposed study will utilize a mixed-methods nested-study approach including two steps
of data collection. Data will be collected using random digit dialing to conduct a cell and landline phone survey
of adult Arkansans (N=1800). Then, we will utilize a purposeful/random sample (N=50) drawn from the phone
survey participants who are hesitant adopters (i.e., expressing both hesitancy and having received the COVID-
19 vaccination) for qualitative data collection. The purposeful sample for the qualitative portion will provide rich
qualitative data on hesitant adopters. Both sampling methods will oversample Black/African American and
Hispanic/Latino participants. Our specific aims are: Aim 1. Examine characteristics associated with vaccine
hesitancy/willingness and vaccine behavior (e.g., vaccinated or not) between and within racial/ethnic groups
using quantitative methods (random sample of N=1800) informed by the Increasing Vaccination Model. Aim 2.
Examine the characteristics that distinguish hesitant adopters from hesitant non-adopters using quantitative
methods (random sample of N=1800) informed by the Increasing Vaccination Model. Aim 3. Examine the role
of thoughts and feelings, social processes, motivations and practical issues in the process of becoming
compliant among those who are hesitant and get vaccinated using qualitative methods (purposeful random
sample N= 50) in a nested design informed by the Increasing Vaccination Model. Although there is much
research documenting the problem of vaccine hesitancy and differences in hesitancy based on race and
ethnicity, almost no studies provide information about what might be done about it. Examining those who are
hesitant but are vaccinated is key to better understanding factors which might increase uptake despite
hesitancy. This study will provide new and actionable information that researchers and healthcare providers
can use to create interventions to increase vaccination uptake among the hesitant.
摘要
COVID-19已成为美国(US)的主要死亡原因之一,种族和民族
少数群体因COVID-19而暴露、住院和死亡的风险更高。人口
通过接种疫苗获得免疫力对于阻止COVID-19的传播至关重要;然而,
疫苗犹豫的种族差异引起了人们对疫苗接种计划是否会进一步扩大的担忧
COVID-19差异。据报道,少数群体对接种COVID-19疫苗更为犹豫,
一些有色人种社区接种COVID-19疫苗的可能性是白人的一半。减少
在COVID-19相关的发病率和死亡率的差异,我们必须了解和解决种族差异,
疫苗行为拟议的研究将采用混合方法嵌套研究方法,包括两个步骤
数据收集。数据将收集使用随机数字拨号进行手机和固定电话调查
阿肯色州成年人(N=1800)。然后,我们将利用从电话中抽取的有目的/随机样本(N=50)
调查犹豫不决的收养者的参与者(即,表示既犹豫又收到了新冠病毒-
19种疫苗)进行定性数据收集。定性部分的有目的的样本将提供丰富的
关于犹豫不决的采用者的定性数据。两种抽样方法都将对黑人/非裔美国人进行过度抽样,
西班牙裔/拉丁裔参与者。我们的具体目标是:目标1。检查与疫苗相关的特征
犹豫/意愿和疫苗行为(例如,接种与否)之间和种族/族裔群体内
使用定量方法(随机样本N=1800),由增加疫苗接种模型提供信息。目标2.
使用定量分析来研究区分犹豫的采纳者和犹豫的非采纳者的特征。
方法(随机样本N=1800)由增加疫苗接种模型告知。目标3.检查的作用
的思想和感情,社会进程,动机和实际问题的过程中,成为
在犹豫不决的人中,使用定性方法接种疫苗(有目的的随机
样本N= 50),采用递增接种模型进行嵌套设计。虽然有很多
记录疫苗犹豫问题和基于种族的犹豫差异的研究,
种族,几乎没有研究提供信息,可以做些什么。检查那些谁是
犹豫但接种疫苗是更好地理解可能增加吸收的因素的关键,
犹豫这项研究将提供新的和可操作的信息,研究人员和医疗保健提供者
可以用来创建干预措施,以增加犹豫不决者的疫苗接种率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lawrence E Cornett其他文献
Identification of β-Adrenergic Receptors Using [3H]Dihydroalprenolol in Fetal Sheep Heart: Direct Evidence of Qualitative Similarity to the Receptors in Adult Sheep Heart
- DOI:
10.1203/00006450-198108000-00002 - 发表时间:
1981-08-01 - 期刊:
- 影响因子:3.100
- 作者:
John B Cheng;Alan Goldfien;Lawrence E Cornett;James M Roberts - 通讯作者:
James M Roberts
Enhanced β2-adrenergic receptor (β2AR) signaling by adeno-associated viral (AAV)-mediated gene transfer
- DOI:
10.1186/1471-2210-3-15 - 发表时间:
2003-12-04 - 期刊:
- 影响因子:2.700
- 作者:
Stacie M Jones;F Charles Hiller;Sandie E Jacobi;Susan K Foreman;Laura M Pittman;Lawrence E Cornett - 通讯作者:
Lawrence E Cornett
Lawrence E Cornett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lawrence E Cornett', 18)}}的其他基金
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
8359800 - 财政年份:2011
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
8168082 - 财政年份:2010
- 资助金额:
$ 25.33万 - 项目类别:
Partnerships for Biomedical Research in Arkansas
阿肯色州生物医学研究伙伴关系
- 批准号:
8076493 - 财政年份:2009
- 资助金额:
$ 25.33万 - 项目类别:
Partnerships for Biomedical Research in Arkansas
阿肯色州生物医学研究伙伴关系
- 批准号:
7892024 - 财政年份:2009
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
7959419 - 财政年份:2009
- 资助金额:
$ 25.33万 - 项目类别:
Partnerships for Biomedical Research in Arkansas
阿肯色州生物医学研究伙伴关系
- 批准号:
7892023 - 财政年份:2009
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
7725051 - 财政年份:2008
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
7609995 - 财政年份:2007
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
7381377 - 财政年份:2006
- 资助金额:
$ 25.33万 - 项目类别:
PARTNERSHIPS FOR BIOMEDICAL RESEARCH IN ARKANSAS: ADMIN CORE
阿肯色州生物医学研究合作伙伴:管理核心
- 批准号:
7170583 - 财政年份:2005
- 资助金额:
$ 25.33万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 25.33万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 25.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




